Pharmacokinetics, Metabolites, and Preclinical Safety of VinflunineLOBERT, Sharon; PUOZZO, Christian.Seminars in oncology. 2008, Vol 35, Num 3, issn 0093-7754, S28-S33, SUP3Article

Vinflunine : A New Microtubule Inhibitor Agent : The development of new cytotoxic agents in clinical oncologyBENNOUNA, Jaafar; DELORD, Jean-Pierre; CAMPONE, Mario et al.Clinical cancer research. 2008, Vol 14, Num 6, pp 1625-1632, issn 1078-0432, 8 p.Article

Antitumor Activity of Vinflunine : Effector Pathways and Potential for SynergiesBRAGUER, Diane; BARRET, Jean-Marc; MCDAID, Hayley et al.Seminars in oncology. 2008, Vol 35, Num 3, issn 0093-7754, S13-S21, SUP3Article

Vinflunine : Discovery and Synthesis of a Novel Microtubule InhibitorFAHY, Jacques; HELLIER, Paul; BREILLOUT, Fabienne et al.Seminars in oncology. 2008, Vol 35, Num 3, issn 0093-7754, S3-S5, SUP3Article

Exploring the Mechanisms of Action of the Novel Microtubule Inhibitor VinflunineJORDAN, Mary Ann; BAND HORWITZ, Susan; LOBERT, Sharon et al.Seminars in oncology. 2008, Vol 35, Num 3, issn 0093-7754, S6-S12, SUP3Article

Clinical Activity of Vinflunine in Transitional Cell Carcinoma of the Urothelium and Other Solid TumorsBELLMUNT, Joaquim; DELGADO, Francois-Michel; GEORGE, Claude et al.Seminars in oncology. 2008, Vol 35, Num 3, issn 0093-7754, S34-S43, SUP3Article

Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cellsPOURROY, Bertrand; HONORE, Stéphane; PASQUIER, Eddy et al.Cancer research (Baltimore). 2006, Vol 66, Num 6, pp 3256-3263, issn 0008-5472, 8 p.Article

Pharmacokinetics, tissue distribution and excretion of vinflunineZHAO, Xiao-Ping; LIU, Xiao-Quan; WANG, Yong-Sheng et al.European journal of drug metabolism and pharmacokinetics. 2006, Vol 31, Num 2, pp 59-64, issn 0378-7966, 6 p.Article

Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunineKRAJEWSKI, Katherine M; FOUGERAY, Ronan; BELLMUNT, Joaquim et al.European journal of cancer (1990). 2012, Vol 48, Num 10, pp 1495-1502, issn 0959-8049, 8 p.Article

Hyponatrémie sévère chez un patient atteint d'un carcinome urothélial traité par chimiothérapieHEIBLIG, M; PICARD, C; GENESTE, M. A et al.JOG, le journal d'oncogériatrie. 2012, Vol 3, Num 5, pp 233-236, issn 2106-8534, 4 p.Article

Further mechanistic unravelling of the influence of the cell cycle effects on the radiosensitising mechanism of vinflunine, in vitroSIMOENS, Cindy; PAUWELS, Bea; VERMORKEN, Jan B et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 2, pp 183-193, issn 0344-5704, 11 p.Article

Phase II study of vinflunine in malignant pleural mesotheliomaTALBOT, Denis C; MARGERY, Jacques; RUFFLE, Pierre et al.Journal of clinical oncology. 2007, Vol 25, Num 30, pp 4751-4756, issn 0732-183X, 6 p.Article

Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitroSIMOENS, Cindy; VERMORKEN, Jan B; KORST, Annelies E. C et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 2, pp 210-218, issn 0344-5704, 9 p.Article

Head and neck carcinoma cell lines are sensitive to vinflunine in vitroERJALA, Kaisa; RAITANEN, Misa; KULMALA, Jarmo et al.Anticancer research. 2005, Vol 25, Num 6B, pp 4363-4367, issn 0250-7005, 5 p.Article

Differential binding to the α/β-tubulin dimer of vinorelbine and vinflunine revealed by nuclear magnetic resonance analysesFABRE, Christine; CZAPLICKI, Jerzy; WRIGHT, Michel et al.Biochemical pharmacology. 2002, Vol 64, Num 4, pp 733-740, issn 0006-2952, 8 p.Article

Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubulesNGAN, Vivian K; BELLMAN, Krista; PANDA, Dulal et al.Cancer research (Baltimore). 2000, Vol 60, Num 18, pp 5045-5051, issn 0008-5472Article

Antimitotic and tubulin^, interacting properties of vinflunine, a novel fluorinated Vinca alkaloidKRUCZYNSKI, A; BARRET, J.-M; ETIEVANT, C et al.Biochemical pharmacology. 1998, Vol 55, Num 5, pp 635-648, issn 0006-2952Article

Phase I dose-escalation study of oral vinflunine in combination with erlotinib in pre-treated and unselected EGFR patients with locally advanced or metastatic non-small-cell lung cancerKRZAKOWSKI, M; BENNOUNA, J; DANSIN, E et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 2, pp 231-236, issn 0344-5704, 6 p.Article

The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunineHARSHMAN, L. C; FOUGERAY, R; CHOUEIRI, T. K et al.British journal of cancer. 2013, Vol 109, Num 10, pp 2548-2553, issn 0007-0920, 6 p.Article

A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancerPARIDAENS, R; RIXE, O; PINEL, M. C et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 4, pp 503-511, issn 0344-5704, 9 p.Article

Synthesis and study of a molecularly imprinted polymer for specific solid-phase extraction of vinflunine and its metabolite from biological fluidsLOPEZ, Claire; CLAUDE, Bérengère; MORIN, Philippe et al.Journal of separation science (Print). 2011, Vol 34, Num 15, pp 1902-1909, issn 1615-9306, 8 p.Article

Development of a sensitive liquid chromatography method coupled with a tandem mass spectrometric detection for the clinical analysis of vinflunine and 4-O-deacetyl vinflunine in blood, urine and faecesZORZA, G; VAN HEUGEN, J. C; DE GRAEVE, J et al.Journal of chromatography. B. 2007, Vol 853, Num 1-2, pp 294-302, issn 1570-0232, 9 p.Article

Actualités du 26th Annual San Antonio Breast Cancer Symposium, San Antonio, 3-6 décembre 2003. Compte-renduDIERAS, V; PIERGA, J. Y.La Lettre du cancérologue (Boulogne). 2004, Vol 13, Num 1, issn 1165-113X, 10 p., SUP2Conference Proceedings

Effets des poisons des microtubules sur le cytosquelette aux doses cytotoxiques = Mictotubule poisons effects on cytoskeleton at cytotoxic concentrationsJean Decoster, Catherine; Wright, Michel.1999, 93 p.Thesis

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancerZAMAN, K; DURANDO, X; BAURAIN, J.-F et al.Breast cancer research and treatment. 2011, Vol 127, Num 3, pp 689-696, issn 0167-6806, 8 p.Article